Literature DB >> 21810628

Altered cortical network dynamics: a potential intermediate phenotype for schizophrenia and association with ZNF804A.

Roberta Rasetti1, Fabio Sambataro, Qiang Chen, Joseph H Callicott, Venkata S Mattay, Daniel R Weinberger.   

Abstract

CONTEXT: Studies have shown patterns of abnormal dorsolateral prefrontal cortex (DLPFC) functional connectivity with other brain areas in schizophrenia and association of these patterns with a putative susceptibility gene (ZNF804A). However, whether these patterns are trait phenomena linked to genetic risk for illness is unclear.
OBJECTIVE: To test the hypotheses that altered DLPFC connectivity is (1) a familial, likely heritable feature of genetic risk for schizophrenia, (2) a novel intermediate phenotype independent of altered DLPFC engagement, and (3) selectively modulated by a polymorphism in ZNF804A.
DESIGN: Cross-sectional case-control study using blood oxygen level-dependent functional magnetic resonance imaging during a working memory task and genotyping of rs1344706 in ZNF804A.
SETTING: Research center. PARTICIPANTS: A total of 402 subjects (153 cognitively normal controls, 171 healthy siblings of patients with schizophrenia, and 78 patients). MAIN OUTCOME MEASURES: Task-independent and task-dependent physiologic coupling between the DLPFC and other brain "target" regions investigated with (1) seeded connectivity and (2) psychophysiological interaction analysis.
RESULTS: Siblings and patients showed greater DLPFC "inefficiency" than controls. Abnormal DLPFC functional coupling with the hippocampus and, to a lesser degree, the rest of the prefrontal cortex, was observed in patients and siblings when compared with controls using both connectivity analyses. Prefrontal activation and connectivity measures within siblings did not correlate, implying that they were independent phenomena. The ZNF804A genotype significantly modulated DLPFC coupling with the hippocampus and prefrontal cortex but not DLPFC activity in the control group. Similarly, ZNF804A genotype modulated right DLPFC-hippocampal formation coupling in siblings and patients.
CONCLUSIONS: Coupling between the DLPFC and hippocampus is compromised in siblings of patients with schizophrenia and is independent of DLPFC engagement. The selective association with a single-nucleotide polymorphism in ZNF804A suggests that this intermediate phenotype proxies a distinct neural system mechanism related to genetic risk for schizophrenia and the biology of this gene.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21810628     DOI: 10.1001/archgenpsychiatry.2011.103

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  81 in total

1.  A schizophrenia risk gene, ZNF804A, is associated with brain white matter microstructure.

Authors:  T Ikuta; B D Peters; S Guha; M John; K H Karlsgodt; T Lencz; P R Szeszko; A K Malhotra
Journal:  Schizophr Res       Date:  2014-03-27       Impact factor: 4.939

2.  Acute ketamine challenge increases resting state prefrontal-hippocampal connectivity in both humans and rats.

Authors:  Oliver Grimm; Natalia Gass; Wolfgang Weber-Fahr; Alexander Sartorius; Esther Schenker; Michael Spedding; Celine Risterucci; Janina Isabel Schweiger; Andreas Böhringer; Zhenxiang Zang; Heike Tost; Adam James Schwarz; Andreas Meyer-Lindenberg
Journal:  Psychopharmacology (Berl)       Date:  2015-07-18       Impact factor: 4.530

3.  Bridging Integrator 1 (BIN1) Genotype Effects on Working Memory, Hippocampal Volume, and Functional Connectivity in Young Healthy Individuals.

Authors:  Xiaolong Zhang; Jin-Tai Yu; Jin Li; Chao Wang; Lan Tan; Bing Liu; Tianzi Jiang
Journal:  Neuropsychopharmacology       Date:  2015-01-29       Impact factor: 7.853

4.  Association of rs1006737 in CACNA1C with alterations in prefrontal activation and fronto-hippocampal connectivity.

Authors:  Frieder M Paulus; Johannes Bedenbender; Sören Krach; Martin Pyka; Axel Krug; Jens Sommer; Miriam Mette; Markus M Nöthen; Stephanie H Witt; Marcella Rietschel; Tilo Kircher; Andreas Jansen
Journal:  Hum Brain Mapp       Date:  2013-02-13       Impact factor: 5.038

5.  Zinc finger protein 804A (ZNF804A) and verbal deficits in individuals with autism.

Authors:  Ayyappan Anitha; Ismail Thanseem; Kazuhiko Nakamura; Mahesh M Vasu; Kazuo Yamada; Takatoshi Ueki; Yoshimi Iwayama; Tomoko Toyota; Kenji J Tsuchiya; Yasuhide Iwata; Katsuaki Suzuki; Toshiro Sugiyama; Masatsugu Tsujii; Takeo Yoshikawa; Norio Mori
Journal:  J Psychiatry Neurosci       Date:  2014-09       Impact factor: 6.186

6.  Effects of ZNF804A on neurophysiologic measures of cognitive control.

Authors:  K Thurin; R Rasetti; F Sambataro; M Safrin; Q Chen; J H Callicott; V S Mattay; D R Weinberger
Journal:  Mol Psychiatry       Date:  2012-10-02       Impact factor: 15.992

7.  Effects of neuregulin 3 genotype on human prefrontal cortex physiology.

Authors:  Heike Tost; Joseph H Callicott; Roberta Rasetti; Radhakrishna Vakkalanka; Venkata S Mattay; Daniel R Weinberger; Amanda J Law
Journal:  J Neurosci       Date:  2014-01-15       Impact factor: 6.167

Review 8.  Neuregulin-ERBB signaling in the nervous system and neuropsychiatric diseases.

Authors:  Lin Mei; Klaus-Armin Nave
Journal:  Neuron       Date:  2014-07-02       Impact factor: 17.173

9.  Effect of schizophrenia risk-associated alleles in SREB2 (GPR85) on functional MRI phenotypes in healthy volunteers.

Authors:  Eugenia Radulescu; Fabio Sambataro; Venkata S Mattay; Joseph H Callicott; Richard E Straub; Mitsuyuki Matsumoto; Daniel R Weinberger; Stefano Marenco
Journal:  Neuropsychopharmacology       Date:  2012-09-12       Impact factor: 7.853

10.  Prefrontal brain network connectivity indicates degree of both schizophrenia risk and cognitive dysfunction.

Authors:  Paul G Unschuld; Alison S Buchholz; Mark Varvaris; Peter C M van Zijl; Christopher A Ross; James J Pekar; Christoph Hock; John A Sweeney; Carol A Tamminga; Matcheri S Keshavan; Godfrey D Pearlson; Gunvant K Thaker; David J Schretlen
Journal:  Schizophr Bull       Date:  2013-06-18       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.